Skip to content

Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

Evaluation of API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05173116
Acronym
EVAL-APIVIGIE
Enrollment
0
Registered
2021-12-29
Start date
2022-02-28
Completion date
2023-08-31
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergencies, Intoxication;Alcohol;Acute

Keywords

Intoxication;Alcohol;Acute, Addiction, Alcohol, binge drinking, young adult

Brief summary

The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal

Detailed description

In France, between 10% and 30% of emergency room admissions are linked to problematic alcohol consumption. This considerable weight of alcohol-related problems in the current problematic of emergencies is largely unknown and can lead to blockages in emergencies. For acute intoxication requiring emergency care, 80% of admissions concern people dependent on alcohol. Here again, this crucial clinical notion is largely ignored: when a patient in a state of intoxication arrives in the emergency room, this should not be considered as a banal and one-off event, it is necessary to put in place a care, if necessary, of addiction. Supported by a call for projects from the Hauts-de-France Regional Health Agency, the Addictions Service of the Arras Hospital is setting up a monitoring system called APIVIGIE. APIVIGIE program is offered to patients who present to the emergency room for a diagnosis of API after an evaluation by the liaison team of the addiction service. If the patient agrees to be part of the program, he will receive a resource card with the APIVIGIE phone number to contact if necessary. The link will be maintained with the Addictology Care, Support and Prevention Center (CSAPA) for a period of 6 months, by telephone consultations, or by video-consultations or face-to-face consultations.

Interventions

OTHERMedical Outcomes Study Short Form 36 (SF 36)

completion of questionnaire quality of life SF 36 (inclusion, Month 3, Month 6).

OTHERobservationnal study

data collection

Sponsors

F2RSM Psy (Hauts-de-France Regional Federation for Research in Psychiatry and Mental Health)
CollaboratorUNKNOWN
Centre Hospitalier Arras
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient 18 years or older; * Participant at API-VIGIE program.

Exclusion criteria

* Patient's opposition to participating in the research; * Persons under legal protection (under tutorship or curatorship); * Person deprived of liberty; * Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frameDescription
Number of visits to the Emergency Reception Service for Significant Paroxysmal Alcoholicsduring 2 years1 year before implementation of the program and up to 1 year after implementation of the program

Secondary

MeasureTime frameDescription
weekly consumption of alcoholic beveragesInclusion , Visit 2 (Month 3) and visit 3 (Month 6)
weekly consumption of other substances (cannabis, other substances)Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)
Quality of life score, measured by the Medical Outcomes Study Short Form 36 (SF-36) health scale score.Inclusion , Visit 2 (Month 3) and visit 3 (Month 6)SF 36 giving a score from 0 to 100. More higher score, more better quality of life.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026